• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: SMITHS MEDICAL ASD, INC. CADD CASSETTE; SET, I.V. FLUID TRANSFER

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

SMITHS MEDICAL ASD, INC. CADD CASSETTE; SET, I.V. FLUID TRANSFER Back to Search Results
Device Problem Nonstandard Device (1420)
Patient Problem Diarrhea (1811)
Event Type  Injury  
Event Description
Called the pt to discuss the current recall of cadd cassettes and she informed me that she is in the hospital.She said that she does not have any cassettes with her and her roommate has been mixing them and bringing them to her in the hospital.She said that she would call us to review the lot numbers once she is out of the hospital.She said this would be the easiest thing to do for her.She was admitted to the hospital on (b)(6) 2023 because she had been having significant diarrhea for a week straight.She is not sure if her doctor is aware of the hospitalization.She had no questions and no additional information was disclosed.Reported to (b)(6) by pt/caregiver.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
CADD CASSETTE
Type of Device
SET, I.V. FLUID TRANSFER
Manufacturer (Section D)
SMITHS MEDICAL ASD, INC.
MDR Report Key17298837
MDR Text Key318929266
Report NumberMW5119259
Device Sequence Number1
Product Code LHI
Combination Product (y/n)N
Number of Events Reported1
Summary Report (Y/N)N
Report Source Voluntary
Reporter Occupation Other Health Care Professional
Type of Report Initial
Report Date 07/03/2023
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received Not provided
Initial Date FDA Received07/10/2023
Patient Sequence Number1
Treatment
EPOPROSTENOL SDV G-VELETRI
Patient Outcome(s) Hospitalization;
Patient SexFemale
-
-